Exosens (EXENS) Stock Statistics & Valuation Metrics

Exosens has a market cap or net worth of €2.91B. The enterprise value is €3.08K.

Exosens has 50,936,750 shares outstanding. The number of shares has decreased by -2.65% in one year.

Exosens’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 10.54%.

The current PE Ratio of Exosens is 96.9. Exosens’s PEG ratio is 1.44.

In the last 12 months, Exosens had revenue of 468.20M and earned 42.70M in profits. Earnings per share was 0.84.

In the last 12 months, operating cash flow was 118.06M and capital expenditures -61.54M, giving a free cash flow of 56.51M billion.

Exosens pays an annual dividend of €0.3, resulting in a dividend yield of 0.52%

Exosens upcoming earnings date is Mar 8, 2027, TBA (Confirmed).

Exosens as a current ratio of 2.46, with Debt / Equity ratio of 59.77%

In the past 12 months, Exosens has paid 18.00M in taxes.

Exosens EV to EBITDA ratio is 18.85, with an EV/FCF ratio of 55.24.

Exosens has €105.20M in cash and marketable securities with €269.50M in debt, giving a net cash position of -€164.30M billion.

Gross margin is 17.43%, with operating margin of 21.83%, and net profit margin of 9.12%.

The average price target for Exosens is €66.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy